Law360 (August 15, 2019, 9:56 PM EDT) -- A Pennsylvania federal judge refused on Thursday to throw out allegations in multidistrict litigation that Actavis, Teva, Mylan and other drugmakers engaged in a “broad overarching conspiracy” to fix generic-drug prices, saying the allegations are sufficiently pled and discovery is needed to determine if they’re true.
In a 36-page order, U.S. District Judge Cynthia M. Rufe said the multiple complaints filed in the MDL had alleged enough overlap and interdependence to plausibly conclude that the alleged collusion between pharmaceutical companies was not limited to a specific generic drug.
“The allegations in plaintiffs’ overarching complaints plausibly allege that defendants engaged in a conspiracy...
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
Create custom alerts for specific article and case topics and so much more!